1)Nagakawa T, Kayahara M, Ikeda S, et al:Biliary tract cancer treatment:results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg 9:569-575, 2002
2)Ito F, Agni R, Rettammel RJ, et al:Resection of hilar cholangiocarcinoma:concomitant liver resection decreases hepatic recurrence. Ann Surg 248:273-279, 2008
3)Kondo S, Hirano S, Ambo Y, et al:Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins:results of a prospective study. Ann Surg 240:95-101, 2004
4)Takada T, Amano H, Yasuda H, et al:Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase Ⅲ multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95:1685-1695, 2002
5)Okusaka T, Ishii H, Funakoshi A, et al:Phase Ⅱ study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 57:647-653, 2006
6)Nakeeb A, Tran KQ, Black MJ, et al:Improved survival in resected biliary malignancies. Surgery. 132:555-563;discission 563-554, 2002
7)McMasters KM, Tuttle TM, Leach SD, et al:Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 174:605-608;discussion 608-609, 1997
8)Rea DJ, Heimbach JK, Rosen CB, et al:Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242:451-458;discussion 458-461, 2005
9)大星 章,下里 幸,板倉 明,他:癌放射線治療の病理.医のあゆみ 61:618-625,1967
10)Furuse J, Okusaka T, Boku N, et al:S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer:a multicenter phase Ⅱ study. Cancer Chemother Pharmacol. 62:849-855, 2008
11)片寄 友,江川新一,海野倫明:胆道疾患 病期による化学療法の選択 胆管癌に対するNeoadjuvant chemotherapy(chemoradiationを含む)の試み.肝・胆・膵 55:969-977,2007